ELL 抗体 (AA 350-450)
Our Local Distributor
北京 101111
Quick Overview for ELL 抗体 (AA 350-450) (ABIN7266923)
抗原
See all ELL 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 350-450
-
原理
- ELL Rabbit pAb
-
序列
- PAVNGKLGVP NGREALLPTP GPPASTDTLS SSTHLPPRLE PPRAHDPLAD VSNDLGHSGR DCEHGEAAAP APTVRLGLPL LTDCAQPSRP HGSPSRSKPK K
-
交叉反应
- 小鼠
-
产品特性
- Polyclonal Antibodies
-
纯化方法
- Affinity purification
-
免疫原
- A synthetic peptide corresponding to a sequence within amino acids 350-450 of human ELL (NP_006523.1).
-
亚型
- IgG
-
-
-
-
应用备注
- WB,1:500 - 1:2000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
别名
- ELL
-
背景
- Elongation factor component of the super elongation complex (SEC, a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Elongation factor component of the little elongation complex (LEC, a complex required to regulate small nuclear RNA (snRNA gene transcription by RNA polymerase II and III. Specifically required for stimulating the elongation step of RNA polymerase II- and III-dependent snRNA gene transcription. ELL also plays an early role before its assembly into in the SEC complex by stabilizing RNA polymerase II recruitment/initiation and entry into the pause site. Required to stabilize the pre-initiation complex and early elongation.,ELL,C19orf17,ELL1,MEN,PPP1R68,Epigenetics & Nuclear Signaling,Cancer,ELL
-
分子量
- 68kDa
-
基因ID
- 8178
-
UniProt
- P55199
抗原
-